All News

Politicians are great gamblers – but the EC President is playing for high stakes by wagering all on the creation of a European Institute of Technology.

Gene therapy is poised to make a commercial breakthrough after Oxford BioMedica agreed global rights for a cancer treatment with Sanofi-Aventis, in a deal with a headline value of €518 million.

What is the DTI's Technology Strategy Board for? One answer comes in this week's UK budget.

Deloitte's take on the budget and R&D tax relief. And other responses on the spending for science.

The latest stop for the Science|Business road show had leading lights in EU policy arguing about what it takes to create a European innovation zone.

Its government will increase science spending by 25 per cent in the next three years – but the UK won’t meet the 3 per cent Lisbon target.